These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 31386809)
1. Colon-Targeted Delivery Facilitates the Therapeutic Switching of Sofalcone, a Gastroprotective Agent, to an Anticolitic Drug via Nrf2 Activation. Kim W; Kim S; Ju S; Lee H; Jeong S; Yoo JW; Yoon IS; Jung Y Mol Pharm; 2019 Sep; 16(9):4007-4016. PubMed ID: 31386809 [TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent. Lee H; Park S; Ju S; Kim S; Yoo JW; Yoon IS; Min DS; Jung Y Mol Pharm; 2021 Apr; 18(4):1730-1741. PubMed ID: 33661643 [TBL] [Abstract][Full Text] [Related]
3. Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activity. Kim W; Lee H; Kim S; Joo S; Jeong S; Yoo JW; Jung Y Eur J Pharmacol; 2019 Dec; 865():172722. PubMed ID: 31614142 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery. Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity. Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034 [TBL] [Abstract][Full Text] [Related]
6. Sofalcone, a gastric mucosa protective agent, increases vascular endothelial growth factor via the Nrf2-heme-oxygenase-1 dependent pathway in gastric epithelial cells. Shibuya A; Onda K; Kawahara H; Uchiyama Y; Nakayama H; Omi T; Nagaoka M; Matsui H; Hirano T Biochem Biophys Res Commun; 2010 Jul; 398(3):581-4. PubMed ID: 20599750 [TBL] [Abstract][Full Text] [Related]
7. Targeting Nrf2/HO-1 signaling by crocin: Role in attenuation of AA-induced ulcerative colitis in rats. Khodir AE; Said E; Atif H; ElKashef HA; Salem HA Biomed Pharmacother; 2019 Feb; 110():389-399. PubMed ID: 30530041 [TBL] [Abstract][Full Text] [Related]
8. Oxidized 5-aminosalicylic acid activates Nrf2-HO-1 pathway by covalently binding to Keap1: Implication in anti-inflammatory actions of 5-aminosalicylic acid. Kang S; Kim W; Jeong S; Lee Y; Nam J; Lee S; Jung Y Free Radic Biol Med; 2017 Jul; 108():715-724. PubMed ID: 28473247 [TBL] [Abstract][Full Text] [Related]
9. FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway. Mei Y; Wang Z; Zhang Y; Wan T; Xue J; He W; Luo Y; Xu Y; Bai X; Wang Q; Huang Y Front Immunol; 2019; 10():2969. PubMed ID: 31969881 [TBL] [Abstract][Full Text] [Related]
10. Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. Yalniz M; Demirel U; Orhan C; Bahcecioglu IH; Ozercan IH; Aygun C; Tuzcu M; Sahin K Inflammation; 2012 Jun; 35(3):1213-21. PubMed ID: 22350949 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of melatonin on myenteric neuron damage in experimental colitis in rats. Shang B; Shi H; Wang X; Guo X; Wang N; Wang Y; Dong L Fundam Clin Pharmacol; 2016 Apr; 30(2):117-27. PubMed ID: 26787455 [TBL] [Abstract][Full Text] [Related]
12. Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement. Yum S; Jeong S; Lee S; Nam J; Kim W; Yoo JW; Kim MS; Lee BL; Jung Y Drug Des Devel Ther; 2015; 9():4247-58. PubMed ID: 26273188 [TBL] [Abstract][Full Text] [Related]
13. Implication of Nrf2/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis. Khodir AE; Atef H; Said E; ElKashef HA; Salem HA Inflammopharmacology; 2017 Feb; 25(1):119-135. PubMed ID: 28050757 [TBL] [Abstract][Full Text] [Related]
14. Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway. Li Y; Shen L; Luo H Int Immunopharmacol; 2016 Nov; 40():24-31. PubMed ID: 27569028 [TBL] [Abstract][Full Text] [Related]
16. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB. Kim W; Nam J; Lee S; Jeong S; Jung Y Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518 [TBL] [Abstract][Full Text] [Related]
17. N-Acetylserotonin is an oxidation-responsive activator of Nrf2 ameliorating colitis in rats. Kang C; Jeong S; Kim J; Ju S; Im E; Heo G; Park S; Yoo JW; Lee J; Yoon IS; Jung Y J Pineal Res; 2023 Jan; 74(1):e12835. PubMed ID: 36214640 [TBL] [Abstract][Full Text] [Related]
18. Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent. Kim W; Lee Y; Jeong S; Nam J; Lee S; Jung Y Arch Pharm Res; 2015 Oct; 38(10):1830-8. PubMed ID: 25860026 [TBL] [Abstract][Full Text] [Related]
19. Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug. Park H; Kim W; Kim D; Jeong S; Jung Y Curr Mol Pharmacol; 2019; 12(4):272-280. PubMed ID: 30848228 [TBL] [Abstract][Full Text] [Related]